Table 5.
Porphyrins | ||||||
Author year/country (ref) | N | Period | Serum-HCB (range in ng/mL) | UP | CP | Comments |
WORKERS | ||||||
Morley 1973/Australia [6] | 54 | 1950's-60's | NA | NS | NS | only 1 worker with high UP |
Burns 1974/USA [7] | 20 | 1973–74 | <1–310 | NS | NS | - |
Currier 1980/USA [8] | 50 | 1974–7 | 3–1121 | NS | ↓ | ↓ CP if HCB > 200 |
Selden 1999/Sweden [21] | 27 | 1980's | NA(9E/18NE) | NS | ↑ | ↑ CPIII in E vs NE |
GENERAL POPULATION | ||||||
NEONATES | ||||||
Ozalla 2002/Spain [18] | 68 | 1997–99 | 0.4–21 | NS | ↓ | ↓ CPI and CPIII |
ADULTS | ||||||
Burns 1975/USA [20] | 120 | 1972 | 0–23 | NS | ↑ | - |
This study/Spain | 242 | 1994 | 2–1616 | NS | ↓ | ↓ CPI and CPIII |
NA: not available. NS: no statistically significant difference. UP: uroporphyrins. CP, CPI and CPIII: coproporphyrins total, I and III. E/NE: number of subjects exposed/non-exposed